Immunisation Weekly Update:

Immunisation education

Register for upcoming immunisation education webinars, including CESPHN’s annual immunisation update. View past webinar recordings on our Immunisation | Education webpage.

ATAGI statement on RSV monoclonal antibody Nirsevimab (Beyfortus®)

On 26 March 2024, ATAGI released a statement on the use of nirsevimab for prevention of severe respiratory syncytial virus (RSV) in infants. It provides clinical advice on the use of the injectable, long-acting monoclonal antibody (mAb) nirsevimab.

ATAGI’s issuing of formal guidance follows the Therapeutic Goods Administration’s November 2023 approval of nirsevimab for use in infants and vulnerable children up to 24 months of age. Nirsevimab bolsters the range of immunisation products approved for use in Australia for the prevention of RSV, which currently also includes the recently approved Arexvy vaccine for those aged 60 years and over.

More detailed advice on the dosing, timing, co-administration, safety, efficacy, effectiveness and anticipated availability of nirsevimab is available in the full ATAGI statement.

Rabies risk in Timor-Leste alert for GPs

The Public Health Unit would like to remind all GPs that NSW Health provides free rabies vaccine and immunoglobulin for people with bites or scratches from bats in Australia, or any animals from rabies-endemic countries.

GPs are reminded to contact the PHU immediately by calling 1300 066 055 for support in assessing the risk, and for supply of free vaccine and immunoglobulin, if required. Rabies post-exposure prophylaxis is time-sensitive, with treatment tailored to the individual affected, the nature and site of the wound, time elapsed, and any treatment provided overseas.

Full patient management details are available on HealthPathways (SES HealthPathways or Sydney HealthPathways) and in the Australian Immunisation Handbook.

See also:

• Pre and Post Travel Assessment – information for GPs and AMSs
• NSW Health webpage Rabies information for travellers – information for patients who are travelling to rabies-endemic countries.

Whooping Cough Alert

Pertussis (Whooping cough) alert for GPs

On 27 March 2024, NSW Health issued an alert to GPs regarding the increase in whooping cough infections. Key messages include:

• Whooping cough continues to increase in NSW, particularly amongst school-aged children.
• Prompt diagnosis, isolation and antibiotics can reduce transmission and protect infants.
• Ensure infants are vaccinated on time, and all pregnant women are vaccinated between 2032 weeks.

See NSW Health full alert: ​​​Pertussis (Whooping Cough) – Information for GPs​

Australian Immunisation Handbook updates

The Australian Immunisation Handbook was updated with new and updated information. A summary of the change can be found below: